Using an epigenetic mechanism, romidepsin restored gene expression and alleviated social deficits in animal model of autism
Of all the challenges that come with a diagnosis of autism spectrum disorder (ASD), the social difficulties are among the most devastating. Currently, there is no treatment for this primary symptom of ASD. New research at the University at Buffalo reveals the first evidence that it may be possible to use a single compound to alleviate the behavioral symptoms by targeting sets of genes involved in the disease.
The research, published today in Nature Neuroscience, demonstrated that brief treatment with a very low dose of romidepsin, a Food and Drug Administration-approved anti-cancer drug, restored social deficits in animal models of autism in a sustained fashion.
The three-day treatment reversed social deficits in mice deficient in a gene called Shank 3, an important risk factor for ASD. This effect lasted for three weeks, spanning the juvenile to late adolescent period, a critical developmental stage for social and communication skills. That is equivalent to several years in humans, suggesting the effects of a similar treatment could potentially be long-lasting, the researchers say.
Profound, prolonged effect
“We have discovered a small molecule compound that shows a profound and prolonged effect on autism-like social deficits without obvious side effects, while many currently used compounds for treating a variety of psychiatric diseases have failed to exhibit the therapeutic efficacy for this core symptom of autism,” said Zhen Yan, PhD, professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB, and senior author on the paper.
The study builds on her previous research from 2015. That work revealed how the loss of Shank 3 disrupts neuronal communications by affecting the function of the NMDA (n-methyl-D-aspartate) receptor, a critical player in regulating cognition and emotion, leading to deficits in social preference that are common in ASD.
In the new research, the UB scientists found they could reverse those social deficits with a very low dose of romidepsin, which, they found, restores gene expression and function using an epigenetic mechanism, where gene changes are caused by influences other than DNA sequences. Yan noted that human genetics studies have suggested that epigenetic abnormalities likely play a major role in ASD.
To pursue these promising findings, Yan has founded a startup company called ASDDR, which was awarded a Small Business Technology Transfer grant from the National Institutes of Health last summer for more than $770,000.
Epigenetics in ASD
Many of the mutations in ASD, Yan explained, result from chromatin remodeling factors, which are involved in dynamically changing the structure of chromatin, the complex of genetic material in the cell nucleus that condenses into chromosomes.
“The extensive overlap in risk genes for autism and cancer, many of which are chromatin remodeling factors, supports the idea of repurposing epigenetic drugs used in cancer treatment as targeted treatments for autism,” said Yan.
She and her colleagues knew that chromatin regulators — which control how genetic material gains access to a cell’s transcriptional machinery — were key to treating the social deficits in ASD, but the challenge was to know how to affect key risk factors at once.
“Autism involves the loss of so many genes,” Yan explained. “To rescue the social deficits, a compound has to affect a number of genes that are involved in neuronal communication.”
To do so, the team turned to a type of chromatin remodeler called histone modifiers. They modify proteins called histones that help organize genetic material in the nucleus so gene expression can be regulated. Since many genes are altered in autism, the UB scientists knew a histone modifier might be effective.
Loosening up chromatin
In particular, they were interested in histone deacetylase (HDAC), a family of histone modifiers that are critically involved in the remodeling of chromatin structure and the transcriptional regulation of targeted genes.
“In the autism model, HDAC2 is abnormally high, which makes the chromatin in the nucleus very tight, preventing genetic material from accessing the transcriptional machinery it needs to be expressed,” said Yan. “Once HDAC2 is upregulated, it diminishes genes that should not be suppressed, and leads to behavioral changes, such as the autism-like social deficits.”
But the anti-cancer drug romidepsin, a highly potent HDAC inhibitor, turned down the effects of HDAC2, allowing genes involved in neuronal signaling to be expressed normally.
“The HDAC inhibitor loosens up the densely packed chromatin so that the transcriptional machinery gains access to the promoter area of the genes; thus they can be expressed,” Yan said.
The rescue effect on gene expression was widespread. When Yan and her co-authors conducted genome-wide screening at the Genomics and Bioinformatics Core at UB’s New York State Center of Excellence in Bioinformatics and Life Sciences, they found that romidepsin restored the majority of the more than 200 genes that were suppressed in the autism animal model they used.
“The advantage of being able to adjust a set of genes identified as key autism risk factors may explain the strong and long-lasting efficacy of this therapeutic agent for autism,” Yan explained. She and her colleagues will continue their focus on discovering and developing better therapeutic agents for autism.
The Latest on: Autism
via Google News
The Latest on: Autism
- Boy with autism denied First Communion at Catholic church: 'That is discrimination,' mom sayson February 28, 2020 at 5:03 am
The reason given by the Catholic church: The boy has autism, and is unable to express the contrition the church requires before receiving Communion.
- Towards the automatic detection of social biomarkers in autism spectrum disorder: introducing the simulated interaction task (SIT)on February 28, 2020 at 2:15 am
Social interaction deficits are evident in many psychiatric conditions and specifically in autism spectrum disorder (ASD), but hard to assess objectively. We present a digital tool to automatically ...
- Global Autism Therapy Market Future Forecast Report 2020 with Latest Industry Developments 2027on February 28, 2020 at 1:24 am
Global Autism Therapy Market report is an ideal guide to attain information or key data about the market, emerging trends, product usage, motivating factors for customers, customer preferences, ...
- See It: Teen With Autism Sinks 3 Pointer, Making His Basketball Dream Come Trueon February 27, 2020 at 8:49 pm
LYNDHURST, N.J. (CBSNewYork) – A local high school senior with autism takes his shot, and recently his hoops dream came true. When the Lyndhurst High School varsity basketball team plays, 18-year-old ...
- Jenni Farley Wants to 'Break the Stigma' & Help Other Parents After Son's Autism Diagnosison February 27, 2020 at 12:52 pm
PEOPLE Now airs live, Monday through Friday, from the Meredith offices in New York City. Catch PEOPLE Now every weekday at 12:00 p.m. ET/9 a.m. PT on People.com or on the PeopleTV app on your favorite ...
- Church is denying First Communion to our son because he has autism, family sayson February 27, 2020 at 11:31 am
What was supposed to be a blessed time for the family of eight-year-old Anthony LaCugna has turned into upset after they were told their son, who has autism, could not participate in his First Holy ...
- Mixing improv with autismon February 27, 2020 at 10:59 am
Most of the time, they didn’t know what would happen next. While that might not seem out of the ordinary for anyone who has ever found themselves doing improvisation, it was a challenge for these ...
- New Jersey Catholic Church under fire for denying First Communion to boy, 8, with autismon February 27, 2020 at 9:16 am
A young boy with autism was denied his First Communion at a New Jersey Catholic church, leaving his parents along with many online, upset. Eight-year-old Anthony LaCugna, who is non-verbal, was denied ...
- Children With Autism Saw Their Learning and Social Skills Boosted After Playing With This AI Roboton February 27, 2020 at 5:08 am
Over half a dozen children with autism played with a green, feathered artificially intelligent robot called Kiwi for the study.
- Horse riding plus brain-building exercises may help kids with autism, ADHDon February 26, 2020 at 2:04 pm
A combination of horseback riding and brain-building activities may help improve motor skills in children with neurodevelopmental conditions like autism-spectrum disorders and ADHD, a small study ...
via Bing News